-
ICD-10-CM Codes
›
-
C00-D49
Neoplasms
›
-
D3A-D3A
Benign neuroendocrine tumors
›
-
D3A-
Benign neuroendocrine tumors
›
2019 ICD-10-CM Diagnosis Code D3A
Benign neuroendocrine tumors
2016 2017 2018 2019 Non-Billable/Non-Specific Code
- D3A should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2019 edition of ICD-10-CM D3A became effective on October 1, 2018.
- This is the American ICD-10-CM version of D3A - other international versions of ICD-10 D3A may differ.
Use AdditionalUse Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
Code AlsoCode Also Help
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
Type 2 ExcludesType 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D3A) and the excluded code together.
The following code(s) above
D3A contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D3A:
- A benign neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells.
- A paraganglioma that is confined to the site of origin, without metastatic potential.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
ICD-10-CM Codes Adjacent To D3A
D36.11 …… of face, head, and neck
D36.12 …… upper limb, including shoulder
D36.13 …… of lower limb, including hip
D36.17 …… of trunk, unspecified
D36.7 Benign neoplasm of other specified sites
D36.9 Benign neoplasm, unspecified site
D3A
Benign neuroendocrine tumors
D3A.0 Benign carcinoid tumors
D3A.00 Benign carcinoid tumor of unspecified site
D3A.01 Benign carcinoid tumors of the small intestine
D3A.010 Benign carcinoid tumor of the duodenum
D3A.011 Benign carcinoid tumor of the jejunum
D3A.012 Benign carcinoid tumor of the ileum
D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion
D3A.02 Benign carcinoid tumors of the appendix, large intestine, and rectum
D3A.020 Benign carcinoid tumor of the appendix
D3A.021 Benign carcinoid tumor of the cecum
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
